{"id":957620,"date":"2026-05-04T09:33:06","date_gmt":"2026-05-04T13:33:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/"},"modified":"2026-05-04T09:33:06","modified_gmt":"2026-05-04T13:33:06","slug":"coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/","title":{"rendered":"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">REDWOOD CITY, Calif., May  04, 2026  (GLOBE NEWSWIRE) &#8212; <strong>Coherus Oncology, Inc<\/strong>.\u00a0(Nasdaq: CHRS), today announced that its first quarter 2026 financial results will be released after market close on Monday, May 11, 2026. Starting at 5:00 p.m. Eastern Time on May 11, 2026, Coherus\u2019 management team will host a conference call and webcast to discuss financial results and provide a general business update.<\/p>\n<p>A webcast replay will be available on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FhFv6cHHvJMwta8JN5HpiCS0hnKWnmcWo3CGkMYWgesA74SMxgfWziIxg_qVfaOpU1KYMi8cFDVxM4HGEDItVfD3x9r3CVkayb835xZtgB7Dbpah1iFGsjv4QtqTnSIQ\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.coherus.com<\/a> following the conclusion of the live conference call.<\/p>\n<p>\n        <strong>Conference Call Information<\/strong>\n      <\/p>\n<p>When: Monday, May 11, 2026, starting at 5:00 p.m. Eastern Standard Time<\/p>\n<p>To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FhFv6cHHvJMwta8JN5HpiKJhzAP2siDYlTWyd3RVKjim0prjE-vJnieFuPibtuzqMU9cN6jPpBcbn7x5yUfUjs77k92QddsEB6hPziw4aODsuWQB-JAp-Z2GpiatnnoG5yE-tHfcyS1__cGE4V7o0w2pY1vZzyd8v9UhC0sxl0VyW0PM3WlAzBexzQN61jMp1cJRXMW7NSGoGmvAI9MDwI2nPMrmsMqDtZ_JjluxkYjUJJm0KSBxw6LCfkGLdo8DL3Hv69r1sSc6Zb05rTIp2bizSLBH7BcAdDd0jASws_9Z75XtEQRsEvBCMPT7QSXBPmrYRvax2fn7xmHTnSakggP_ouPOTNFpGamixHr0_IrbE32KV4StHrSCwx3EE8NW4eLYFrD3xStxF6uaVd7hmzJwKq4MrjW0f8W_Wr5scgTXqVvDI7GNepW87OS4E1RSJSZU4BAmACpxZZWWzyUAWwFHP09iYgDiFngRec-1UrbUb-2_BP2CCmu73FeEB3CzE-i8o44HU6Lo5fc267A817OGN3kzr4UfVtBFr_1cfysodfzqQK0AS38L4MYW37AvI4Cpwrlx5psQoUgo4DrYHunjq6ndXm05QUqSguOYwVLwLQjmg5Ul5gh62WaG9Rbx0OieaRaShjRAZha1JiY0CVZqI6xURXntWPtCPfRKgd5lBg_ZJAi15q9oJUIyjnHKQ6g2gmsSVPolgBkBg13FEjNS5iZrapSFErRHok-t_2tz9k64Vq6sQdqIT0CxyHxB-0kEamoQ5k6cqi5vRWDuZA==\" rel=\"nofollow\" target=\"_blank\">https:\/\/register-conf.media-server.com\/register\/BI717266b2e2e943cb92bb04def907b571<\/a>.<\/p>\n<p>Webcast: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FhFv6cHHvJMwta8JN5HpiNXtrp1Nk65HvDC9JW6vBsa85f_4SNY12537_rrPESABBGv1e0Bq4O3jlPAqgbt2pwrwWF1zH4chKkzBNXqFlTjXfTCcMtmmi1Rn1APupJtU0_fzRAQ8o5x5hGbcM6sAs2vOk4WsUPC8JOO-z-dmIP4=\" rel=\"nofollow\" target=\"_blank\">https:\/\/edge.media-server.com\/mmc\/p\/orxawzr2<\/a>.<\/p>\n<p>The press release with the first quarter 2026 financial results and related materials will be available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FhFv6cHHvJMwta8JN5HpiCS0hnKWnmcWo3CGkMYWgetamiR2dGqVLSb_0MTUlVhQivEGihu_jusDRk8BQlGTN2_a8B-xsYepgOu7spYKR2nZ9yGBdoJujZZVgTQdYoht\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.coherus.com<\/a> before the start of the conference call.<\/p>\n<p>A live and archived webcast will be available on the \u201cInvestors\u201d section of the Coherus website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FhFv6cHHvJMwta8JN5HpiCS0hnKWnmcWo3CGkMYWgevMIXHDLW1seGbWj8DzrJ3S8XrDlIX0oD6iVN8Blsnt0X5qA4_vAMLfTg3CCvUB5_eeN04tAMUeeVlaxo2L6ZfK8w_xl0GZ8BstfHHd5Ef41ArpRr85PK5DbWRlqdpezRY=\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.coherus.com\/events-presentations<\/a>.<\/p>\n<p>Please dial in15 minutes early to ensure a timely connection to the call.<\/p>\n<p>\n        <strong>Disclosure Information<\/strong>\n      <\/p>\n<p>Coherus uses the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FhFv6cHHvJMwta8JN5HpiCS0hnKWnmcWo3CGkMYWgevz-xnvuyK0xLbDtc9ovKI-IY0hlwfXPCJ497MZfUsSt7M4nUVKk1RcWUCikWY8o9vOV-ynD69mJj0W5jPlSGD7\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.coherus.com<\/a>\u202fwebsite as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.\u202f<\/p>\n<p>\n        <strong>About Coherus Oncology<\/strong><\/p>\n<p>Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation programmed death receptor-1 (\u201cPD-1\u201d) inhibitor, LOQTORZI<sup>\u00ae<\/sup> (toripalimab-tpzi), and a pipeline that includes two mid-stage clinical candidates targeting liver, prostate, head &amp; neck, colorectal and other cancers. The Company\u2019s strategy is to grow sales of LOQTORZI in R\/M Nasopharyngeal Carcinoma and advance the development of its two pipeline candidates in combination with LOQTORZI and through strategic partnerships.<\/p>\n<p>Coherus\u2019 innovative oncology pipeline includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor response and enhance outcomes for patients with cancer. Tagmokitug is a highly selective cytolytic anti-CCR8 antibody currently in Phase 1b\/2a studies in patients with advanced solid tumors; including head and neck squamous cell carcinoma, colorectal cancer, gastric, gastro-esophageal-junction, esophageal adenocarcinoma and esophageal squamous cell carcinoma. Casdozokitug is a novel IL-27 antagonistic antibody currently being evaluated in a Phase 2 study in patients with first-line hepatocellular carcinoma.<\/p>\n<p>LOQTORZI<sup>\u00ae<\/sup> is a registered trademark of Coherus Oncology, Inc.<br \/>\u00a92026 Coherus Oncology, Inc. All rights reserved.<\/p>\n<p>\n        <strong>Coherus Oncology Contact Information:<\/strong>\n      <\/p>\n<p>For Investors:<\/p>\n<p>Carrie Graham<br \/>Vice President, Investor Relations &amp; Advocacy<br \/>IR@coherus.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTZiMWQ0M2QtYWVhYi00OTVjLTg1NTktYzJhZjczYzlkYTNiLTEwMjI3MzEtMjAyNi0wNS0wNC1lbg==\/tiny\/Coherus-Oncology.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REDWOOD CITY, Calif., May 04, 2026 (GLOBE NEWSWIRE) &#8212; Coherus Oncology, Inc.\u00a0(Nasdaq: CHRS), today announced that its first quarter 2026 financial results will be released after market close on Monday, May 11, 2026. Starting at 5:00 p.m. Eastern Time on May 11, 2026, Coherus\u2019 management team will host a conference call and webcast to discuss financial results and provide a general business update. A webcast replay will be available on https:\/\/investors.coherus.com following the conclusion of the live conference call. Conference Call Information When: Monday, May 11, 2026, starting at 5:00 p.m. Eastern Standard Time To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https:\/\/register-conf.media-server.com\/register\/BI717266b2e2e943cb92bb04def907b571. Webcast: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-957620","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REDWOOD CITY, Calif., May 04, 2026 (GLOBE NEWSWIRE) &#8212; Coherus Oncology, Inc.\u00a0(Nasdaq: CHRS), today announced that its first quarter 2026 financial results will be released after market close on Monday, May 11, 2026. Starting at 5:00 p.m. Eastern Time on May 11, 2026, Coherus\u2019 management team will host a conference call and webcast to discuss financial results and provide a general business update. A webcast replay will be available on https:\/\/investors.coherus.com following the conclusion of the live conference call. Conference Call Information When: Monday, May 11, 2026, starting at 5:00 p.m. Eastern Standard Time To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https:\/\/register-conf.media-server.com\/register\/BI717266b2e2e943cb92bb04def907b571. Webcast: &hellip; Continue reading &quot;Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-04T13:33:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026\",\"datePublished\":\"2026-05-04T13:33:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/\"},\"wordCount\":428,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/\",\"name\":\"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=\",\"datePublished\":\"2026-05-04T13:33:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/","og_locale":"en_US","og_type":"article","og_title":"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 - Market Newsdesk","og_description":"REDWOOD CITY, Calif., May 04, 2026 (GLOBE NEWSWIRE) &#8212; Coherus Oncology, Inc.\u00a0(Nasdaq: CHRS), today announced that its first quarter 2026 financial results will be released after market close on Monday, May 11, 2026. Starting at 5:00 p.m. Eastern Time on May 11, 2026, Coherus\u2019 management team will host a conference call and webcast to discuss financial results and provide a general business update. A webcast replay will be available on https:\/\/investors.coherus.com following the conclusion of the live conference call. Conference Call Information When: Monday, May 11, 2026, starting at 5:00 p.m. Eastern Standard Time To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https:\/\/register-conf.media-server.com\/register\/BI717266b2e2e943cb92bb04def907b571. Webcast: &hellip; Continue reading \"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-04T13:33:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026","datePublished":"2026-05-04T13:33:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/"},"wordCount":428,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/","name":"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=","datePublished":"2026-05-04T13:33:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjE2MyM3NTUzNDA4IzIwMTExNTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=957620"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957620\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=957620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=957620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=957620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}